2023-11-08T23:06:12-06:00 2022-12-31 221478099 COHNREZNICK LLP 7501 WISCONSIN AVENUE SUITE 400E BETHESDA MD 20814 990 2022-01-01 833561693 ASCO ASSOCIATION ASCO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 LINDA A JENSEN EVP & CFO 5714831300 2023-11-07 1 LINDA JENSEN 999009999 1 LORI ROTHE YOKOBOSKY CPA P01273422 3016529100 2023-11-06 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z ASSOCIATION FOR CLINICAL ONCOLOGY CLIFFORD HUDIS MD CEO 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 15448005 0 X WWW.ASCOASSOCIATION.ORG X 2019 VA OUR MISSION IS TO CONQUER CANCER THROUGH ADVOCACY FOR RESEARCH, EDUCATION, AND THE PROMOTION OF THE HIGHEST QUALITY, EQUITABLE PATIENT CARE. 10 10 49 4205 375950 252559 74000 58500 14153284 15152807 0 4083 35681 232615 14262965 15448005 105000 145667 0 0 5390547 6166450 0 0 0 7035496 7994613 12531043 14306730 1731922 1141275 7233977 4082175 17632321 13328762 -10398344 -9246587 X ASCO ASSOCIATION PROMOTES THE COMMON BUSINESS INTERESTS OF ITS MEMBERS BY: (1) ADVOCATING FOR POLICIES THAT IMPROVE THE QUALITY OF CANCER CARE; (2) MAINTAINING THE HIGHEST STANDARDS OF ONCOLOGY MEDICAL CARE THROUGH PROGRAMS SUPPORTING EDUCATION, (CONTINUED IN SCHEDULE O) RESEARCH, AND QUALITY IMPROVEMENT; AND (3) INCREASING AWARENESS AMONG THE MEDICAL COMMUNITY, PATIENTS, AND THE PUBLIC OF CHALLENGES FACED BY ONCOLOGY MEDICAL PROFESSIONALS THAT MAY AFFECT QUALITY OF CANCER CARE. 0 0 SEE SCHEDULE O:MEMBER SERVICES: THE ASSOCIATION WORKS TO SUPPORT AND EDUCATE ITS GLOBAL NETWORK OF NEARLY 45,000 ONCOLOGY PROFESSIONAL MEMBERS, MAINTAINING ONLINE FORUMS THAT ALLOW MEMBERS TO DISCUSS ISSUES OF PROFESSIONAL INTEREST, SUPPORTING INTERNATIONAL REGIONAL COUNCILS, AND RECRUITING MEMBERS FOR, AND TRACKING PARTICIPATION IN, VOLUNTEER ACTIVITIES RELATED TO THE ASSOCIATION, INCLUDING SERVING ON COMMITTEES. SEE SCHEDULE O:ACCREDITATION & CERTIFICATION: THE ASSOCIATION CONDUCTS AN ACCREDITATION PROGRAM THAT PROMOTES THE PRACTICE OF ITS MEMBERS BY MAINTAINING AND IMPROVING THE QUALITY OF MEDICAL CARE AVAILABLE TO THE PUBLIC AND MAINTAINING HIGH STANDARDS OF EXCELLENCE IN ONCOLOGY. THE QUALITY ONCOLOGY PRACTICE INITIATIVE (QOPI) CERTIFICATION PROGRAM ("QCP") PROVIDES A THREE-YEAR CERTIFICATION RECOGNIZING HIGH-QUALITY CARE FOR OUTPATIENT HEMATOLOGY-ONCOLOGY PRACTICES. THE QCP STANDARDS WERE ADAPTED FROM THE CHEMOTHERAPY ADMINISTRATION SAFETY STANDARDS CODEVELOPED BY ASCO AND THE ONCOLOGY NURSING SOCIETY (ONS). THEY ARE INTENDED TO REDUCE THE RISK OF ERRORS AND PROMOTING THE SAFE HANDLING OF CHEMOTHERAPY AGENTS. PARTICIPATING PRACTICES RECEIVE SITE SURVEYS BY EXPERIENCED ONCOLOGY PROFESSIONALS TO ASSESS COMPLIANCE WITH ALL QCP STANDARDS THROUGH INTERVIEWS, OBSERVATION, AND MEDICAL RECORD REVIEWS. PARTICIPANTS RECEIVE REPORTS DOCUMENTING THEIR LEVEL OF COMPLIANCE WITH EACH CERTIFICATION STANDARD AND MAKING RECOMMENDATIONS OR REQUIREMENTS FOR IMPROVED CARE. QCP CERTIFICATION RECOGNIZES HIGH PERFORMING PRACTICES AND IS NOT REQUIRED FOR ANY PROFESSIONAL LICENSING, NOR IS IT REQUIRED OF THE ASSOCIATION'S MEMBERS. 320 HEMATOLGY-ONCOLOGY PRACTICES WERE ACTIVELY CERTIFIED IN 2022. SEE SCHEDULE O:ADVOCACY: THE ASSOCIATION'S ADVOCACY WORK FOCUSES ON ASSURING HIGH-QUALITY CARE FOR ALL PATIENTS WITH CANCER. WORKING WITH VOLUNTEER MEMBERS AND AFFILIATED STATE AND REGIONAL ONCOLOGY SOCIETIES, ASCO ENGAGES WITH THE ADMINISTRATION, CONGRESS, AND STATE LAWMAKERS TO ADDRESS ISSUES OF CRITICAL IMPORTANCE TO CANCER CARE AND RESEARCH. THE ASSOCIATION'S ADVOCACY PORTFOLIO INCLUDES CLINICAL RESEARCH, INSURANCE COVERAGE FOR CANCER CARE, CLINICAL PRACTICE, WORKFORCE, DISPARITIES, COST AND ACCESS, SURVIVORSHIP, AND CANCER PREVENTION. ADVOCACY ACTIVITIES INCLUDE TRACKING, ANALYZING, AND INFLUENCING PENDING LEGISLATION AND REGULATIONS, AND EDUCATING BOTH MEMBERS AND POLICYMAKERS ABOUT THE IMPACT OF POLICY ON CANCER PATIENTS, CLINICIANS, AND CLINICAL RESEARCH. IN 2022, THE ASSOCIATION WAS SUCCESSFUL IN ITS EFFORTS TO OBTAIN INCREASED FUNDING FOR CANCER RESEARCH, WITH A $2.5 BILLION NIH FUNDING INCREASE OVER FY22 AND A $408 MILLION NCI FUNDING INCREASE OVER FY22, INCLUDING FULL FUNDING FOR THE FINAL YEAR OF THE CANCER MOONSHOT. ADDITIONALLY, THE FISCAL YEAR 2023 SPENDING PACKAGE PASSED BY CONGRESS REDUCED THE 4.47% CUT IN THE MEDICARE PHYSICIAN FEE SCHEDULE FINAL RULE BY 2.5%, LEADING TO A FINAL ESTIMATED CUT OF APPROXIMATELY 2% FOR 2023; WAIVED THE 4% MEDICARE STATUTORY PAY-AS-YOU-GO (PAYGO) CUT FOR 2023 AND 2024; AND EXTENDED THE ADVANCED ALTERNATIVE PAYMENT MODEL BONUS, PROVIDING A 3.5% INCENTIVE PAYMENT (DOWN FROM 5%) FOR 2023. FINALLY, THE HOUSE OF REPRESENTATIVES PASSED PRIOR AUTHORIZATION LEGISLATION, HR 3173, THE IMPROVING SENIORS' TIMELY ACCESS TO CARE ACT, AND MORE THAN HALF THE SENATE COSPONSORED PRIOR AUTHORIZATION LEGISLATION, THE MOST EVER. IN THE STATES, STEP THERAPY LAWS UPDATED IN COLORADO, KENTUCKY, MASSACHUSETTS, AND TENNESSEE; PRIOR AUTHORIZATION LAWS PASSED IN MICHIGAN AND LOUISIANA; AND A COMBINED PRIOR AUTHORIZATION AND STEP THERAPY LAW WAS ENACTED IN PENNSYLVANIA. ADDITIONALLY, COPAY ACCUMULATORS BANS WERE ENACTED IN MAINE, WASHINGTON, AND DELAWARE. ASCO ALSO SUPPORTED FEDERAL AGENCY POLICIES THAT RESULTED IN EXPANDED ACCESS TO ACA MARKETPLACE HEALTH PLANS (CURRENTLY A 13% INCREASE IN ENROLLMENT THIS YEAR COMPARED TO LAST), EXPANDED ACCESS TO COLORECTAL SCREENING FOR MEDICARE BENEFICIARIES, AND FIXED A LOOPHOLE IN THE ACA THAT HAD PREVIOUSLY PRESENTED A BARRIER TO ACCESS FOR SOME FAMILY MEMBERS OF INDIVIDUALS WITH AVAILABLE EMPLOYER-SPONSORED COVERAGE. 0 0 0 1 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0 1 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 1 1 1 0 0 1 24 0 1 49 1 1 1 0 0 0 1 1 0 0 0 X 10 10 0 0 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 1 0 VA X LINDA JENSEN EVP & CFO 5714831300 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 HOWARD A BURRIS III MD BOARD CHAIR (THRU 6/22) 1.00 X X 0 0 0 LORI J PIERCE MD BOARD CHAIR (START 6/22) 1.00 1.00 X 0 0 0 JULIE VOSE MD MBA TREASURER (THRU 6/22) 1.00 X X 0 0 0 JASON R WESTIN MD MS TREASURER (START 6/22) 1.00 X X 0 0 0 ETHAN M BASCH MD MSC BOARD MEMBER (START 6/22) 1.00 1.00 X 0 0 0 A WILLIAM BLACKSTOCK MD BOARD MEMBER (THRU 6/22) 1.00 1.00 X 0 0 0 LAURIE E GASPAR MD MBA BOARD MEMBER (THRU 6/22) 1.00 1.00 X 0 0 0 XYLINA T GREGG MD BOARD MEMBER (START 6/22) 1.00 X 0 0 0 LEE M ELLIS MD BOARD MEMBER (THRU 6/22) 1.00 X 0 0 0 CHARLES F MILLER MD BOARD MEMBER (THRU 6/22) 1.00 X 0 0 0 ELIZABETH A MITTENDORF MD PHD MHC BOARD MEMBER 1.00 1.00 X 0 0 0 TONY S K MOK MD BOARD MEMBER (THRU 6/22) 1.00 1.00 X 0 0 0 ELIZABETH R PLIMACK MD MS BOARD MEMBER (START 6/22) 1.00 1.00 X 0 0 0 LYNN M SCHUCHTER MD BOARD MEMBER 1.00 1.00 X 0 0 0 MICHAEL THOMPSON MD PHD BOARD MEMBER (START 6/22) 1.00 X 0 0 0 EVERETT E VOKES MD BOARD MEMBER 1.00 1.00 X 0 0 0 TRACEY F WEISBERG MD BOARD MEMBER (THRU 6/22) 1.00 1.00 X 0 0 0 ERIC P WINER MD BOARD MEMBER 1.00 1.00 X 0 0 0 CLIFFORD A HUDIS MD CEO 1.00 36.50 X 0 930020 22875 LINDA JENSEN EVP & CFO 6.50 30.50 X 0 431666 39119 MELISSA TAI ESQ SECRETARY 8.00 29.50 X 0 297163 44846 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 37.50 X 201846 0 37755 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 19.00 18.50 X 283275 0 43379 KAREN HAGERTY CHIEF REGULATORY AFFAIRS OFFICER 37.50 X 217307 0 23901 RONDA BOWMAN SENIOR DIRECTOR, QCP 37.50 X 190301 0 27006 TERRY COX DIRECTOR, AFFILIATE RELATIONS 37.50 X 148611 0 28226 FLORENCE FREEMAN DIVISION DIRECTOR, MEMBERSHIP 37.50 X 163169 0 11923 SHIMERE SHERWOOD DIRECTOR, SCIENCE & RESEARCH POLICY 37.50 0.00 X 147902 0 10991 1352411 1658849 290021 18 0 1 0 WOLTERS KLUWER HEALTH 351 WEST CAMDEN ST BALTIMORE MD 21201 DESIGN, PRINT, MAIL 2361341 TIBER CREEK GROUP INC 750 9TH ST NW SUITE 501 WASHINGTON DC 20001 PUBLIC AFFAIRS 240000 QUAD GRAPHICS INC 160 CENTURY LANE WINCHESTER VA 22603 DESIGN, PRINT, MAIL 204614 FIGMD INC 6952 ROTE ROAD SUITE 400 ROCKFORD IL 61107 DATA MANAGEMENT 124911 HBP INC 2818 FALLFAX DRIVE FALLS CHURCH VA 22042 DESIGN, PRINT, MAIL 123704 7 58500 58500 MEMBER DUES 813920 13551029 13551029 CERTIFICATION INCOME 813920 927058 927058 ADVERTISING 541800 375950 375950 MEMBER SERVICES 813920 298770 298770 15152807 4083 4083 232615 232615 15448005 14776857 375950 236698 X 145667 326654 4720086 292983 495835 330892 22800 240000 2080831 235418 211868 841239 320828 246581 UBI TAX 55067 PRINTING, POSTAGE & PUB 2693655 SHARED SERVICES 591809 BANK & CREDIT CARD FEES 372255 82262 14306730 6730303 1795125 164903 166835 13751 105651 2014564 325020 0 7233977 4082175 224365 302756 11651922 11990236 5756034 1035770 17632321 13328762 X -10398344 -9246587 -10398344 -9246587 7233977 4082175 1141275 10481 1 0 X X 0 1 X 1 0 0 0 0 13496513 405467 405467 1349651 -944184 0 DUE TO ASCO 1035770 1035770 X PART X, LINE 2: IN PART: THE ASSOCIATION IS A NON-PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(6) OF THE IRC AS A TRADE ASSOCIATION. QCP IS A DISREGARDED ENTITY AND INCLUDED IN THE ASSOCIATION'S INCOME TAX RETURN. THE PAC IS A SEPARATE SEGREGATED FUND OF THE ASSOCIATION CLASSIFIED UNDER SECTION 527 OF THE IRC. THE ASSOCIATION RECEIVED TAXABLE REVENUE RELATED TO ADVERTISING. THE ORGANIZATION ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES IN ACCORDANCE WITH THE INCOME TAX TOPIC OF THE FINANCIAL ACCOUNTING STANDARDS BOARD ACCOUNTING STANDARDS CODIFICATION ("FASB ASC"). THE ORGANIZATION BELIEVES THAT IT HAS APPROPRIATE SUPPORT FOR ANY TAX POSITIONS TAKEN AND, AS SUCH, DOES NOT HAVE ANY UNCERTAIN TAX POSITIONS THAT ARE MATERIAL TO THE CONSOLIDATED FINANCIAL STATEMENTS. EUROPE (INCLUDING ICELAND & GREENLAND) - ALBANIA, ANDORRA, AUSTRIA, BELGIUM 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 33319 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES QUALITY CERTIFICATION FEES 116681 0 0 0 0 0 0 150000 0 150000 0 0 0 0 0 1 PART I, LINE 3: THE ACCRUAL METHOD IS USED TO TRACK AND ACCOUNT FOR FOREIGN EXPENDITURES. PART III ACCOUNTING METHOD: 1 FRIENDS OF CANCER RESEARCH 1800 M STREET NW STE 1050 WASHINGTON DC 20036 521983273 501(C)(3) 25000 0 CANCER RESEARCH REGENTS OF THE UNIVERSITY OF MICHIGAN G395 WOLVERINE TOWER LOW RISE ANN ARBOR MI 48109 386006309 501(C)(3) 54167 0 CANCER RESEARCH 2 0 PART I, LINE 2: GRANTS ARE MADE TO SELECT ORGANIZATIONS WHOSE MISSION INVOLVES CANCER CARE, EDUCATION OR RESEARCH. GRANTS ARE DESIGNATED FOR SCIENTIFIC, EDUCATIONAL OR RESEARCH PURPOSES. 0 0 0 CLIFFORD A HUDIS MD CEO 0 928832 0 0 0 1188 0 22875 0 0 0 952895 0 0 LINDA JENSEN EVP & CFO 0 419380 0 10000 0 2286 0 22875 0 16244 0 470785 0 0 MELISSA TAI ESQ SECRETARY 0 290893 0 6000 0 270 0 22500 0 22346 0 342009 0 0 KRISTA BARNES VICE PRESIDENT, MEMBER SERVICES 272861 0 10000 0 414 0 21000 0 22379 0 326654 0 0 0 KAREN HAGERTY CHIEF REGULATORY AFFAIRS OFFICER 211393 0 5500 0 414 0 15759 0 8142 0 241208 0 0 0 JENNIFER BRUNELLE CHIEF ADVOCACY OFFICER 201576 0 0 0 270 0 15376 0 22379 0 239601 0 0 0 RONDA BOWMAN SENIOR DIRECTOR, QCP 179613 0 9500 0 1188 0 13732 0 13274 0 217307 0 0 0 TERRY COX DIRECTOR, AFFILIATE RELATIONS 148341 0 0 0 270 0 11474 0 16752 0 176837 0 0 0 FLORENCE FREEMAN DIVISION DIRECTOR, MEMBERSHIP 159969 0 3200 0 0 0 11923 0 0 0 175092 0 0 0 SHIMERE SHERWOOD DIRECTOR, SCIENCE & RESEARCH POLICY 147722 0 0 0 180 0 10991 0 0 0 158893 0 0 0 PART I, LINE 3 COMPENSATION FOR THE CEO IS ESTABLISHED BY THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY, INC. (SOCIETY), A SECTION 501(C)(3) ORGANIZATION. THE METHODS USED BY THE SOCIETY IN DETERMINING THE CEO'S COMPENSATION INCLUDE COMPENSATION COMMITTEE, INDEPENDENT COMPENSATION CONSULTANT, FORM 990 OF OTHER ORGANIZATIONS, WRITTEN EMPLOYMENT CONTRACT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD AND COMPENSATION COMMITTEE. UNDER A SHARED SERVICES AGREEMENT BETWEEN THE SOCIETY AND THE ASSOCIATION, THE ASSOCIATION PAYS THE SOCIETY FOR TIME SPENT BY THE CEO ON ASSOCIATION MATTERS. FORM 990, PART VI, SECTION A, LINE 1A DURING THE REPORTING YEAR, THE BOARD OF DIRECTORS DELEGATED AUTHORITY TO ACT ON ITS BEHALF TO THE EXECUTIVE COMMITTEE OF THE BOARD OF DIRECTORS, CONSISTENT WITH THE ASSOCIATION'S BYLAWS. PURSUANT TO THE BYLAWS, THE VOTING MEMBERS OF THE EXECUTIVE COMMITTEE ARE THE CHAIR, TREASURER, AND ONE OR MORE VOTING MEMBERS OF THE BOARD OF DIRECTORS. THE CEO IS A NON-VOTING MEMBER OF THE EXECUTIVE COMMITTEE. ALL EXECUTIVE COMMITTEE MEMBERS ARE MEMBERS OF THE ASSOCIATION'S BOARD OF DIRECTORS. THE SCOPE OF THE EXECUTIVE COMMITTEE'S AUTHORITY IS ESTABLISHED BY THE ASSOCIATION'S EXECUTIVE COMMITTEE CHARTER, WHICH WAS APPROVED BY THE ASSOCIATION'S BOARD OF DIRECTORS. THE CHARTER PROVIDES THAT, EXCEPT TO THE EXTENT SPECIFICALLY PROHIBITED BY THE BYLAWS, RESOLUTION OF THE BOARD OF DIRECTORS, OR APPLICABLE LAW, THE EXECUTIVE COMMITTEE IS EMPOWERED TO MAKE AND IMPLEMENT MAJOR DECISIONS BETWEEN BOARD MEETINGS AND IT MAY ACT ON ITEMS REQUIRING ACTION PRIOR TO THE NEXT ANNOUNCED BOARD MEETING. ALL ACTIONS OF THE EXECUTIVE COMMITTEE ARE REPORTED TO THE BOARD OF DIRECTORS AT THE NEXT MEETING OF THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 6 NONE OF THE ASSOCIATION'S MEMBERS HAS THE RIGHT TO RECEIVE A SHARE OF THE ORGANIZATION'S PROFITS OR EXCESS DUES OR A SHARE OF THE ORGANIZATION'S NET ASSETS UPON DISSOLUTION. MEMBERSHIP IS LIMITED TO ONCOLOGY MEDICAL PROFESSIONALS, DEFINED AS INDIVIDUALS WHOSE PROFESSIONAL CREDENTIALS AND ACTIVITIES INVOLVE CANCER PATIENT CARE AND/OR RESEARCH, EDUCATION, OR ADVOCACY IN THE BIOLOGY, DIAGNOSIS, PREVENTION, OR TREATMENT OF HUMAN CANCER; THOSE INDIVIDUALS WHO ARE RETIRED FROM PROFESSIONAL ACTIVITIES, BUT WHOSE PROFESSIONAL ACTIVITIES PRIOR TO RETIREMENT INCLUDED THOSE DESCRIBED ABOVE; AND THOSE INDIVIDUALS WHO ARE STUDENTS TRAINING TO BE PROFESSIONALS DESCRIBED ABOVE. THE CATEGORY OF MEMBERSHIP WITH VOTING RIGHTS IS VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7A ALL ASCO MEMBERS ARE MEMBERS OF BOTH THE ASSOCIATION AND ITS AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). VOTING MEMBERS OF ASCO ELECT ALL MEMBERS OF THE SOCIETY BOARD OF DIRECTORS. THE MEMBERS OF THE SOCIETY BOARD OF DIRECTORS WHO ARE IN THE FINAL YEAR OF THEIR TERMS, AND THE SOCIETY'S ELECTED OFFICERS, WHO ARE ALL ELECTED BY THE ASCO VOTING MEMBERS, SERVE AS EX-OFFICIO VOTING MEMBERS OF THE ASSOCIATION BOARD OF DIRECTORS. THE CATEGORY OF ASCO MEMBERS WHO ARE ELIGIBLE TO VOTE FOR THE ELECTION OF MEMBERS OF THE SOCIETY BOARD OF DIRECTORS ARE VOTING MEMBERS, WHO ARE DEFINED AS THOSE ONCOLOGY MEDICAL PROFESSIONAL MEMBERS THAT HAVE BEEN AWARDED AND HOLD THE DEGREE OF DOCTOR OF MEDICINE, DOCTOR OF OSTEOPATHY, DOCTOR OF PHILOSOPHY, DOCTOR OF PHARMACY, DOCTOR OF MEDICAL SCIENCE, DOCTOR OF NURSING SCIENCE, DOCTOR OF NURSING PRACTICE, OR EQUIVALENT DOCTORAL-LEVEL DEGREE. FORM 990, PART VI, SECTION A, LINE 7B VOTING MEMBERS HAVE THE RIGHT TO VOTE ON CHANGING THE PURPOSE OF THE ASSOCIATION (AS SET FORTH IN THE BYLAWS), VOLUNTARY DISSOLUTION OF THE ASSOCIATION, AND ANY SUCH MATTERS THAT THE BOARD OF DIRECTORS BRINGS TO THE MEMBERSHIP FOR VOTE. FORM 990, PART VI, SECTION B, LINE 11B A DRAFT ELECTRONIC COPY OF THE ASSOCIATION'S FORM 990 WAS SENT, THROUGH A SECURE SITE, TO EACH MEMBER OF THE BOARD OF DIRECTORS. IN ADDITION, BEFORE FILING, THE FORM WAS REVIEWED BY THE CFO AND CHIEF LEGAL OFFICER. FORM 990, PART VI, SECTION B, LINE 12C THE ASSOCIATION MAINTAINS A NUMBER OF WRITTEN CONFLICT OF INTEREST POLICIES AND STANDARDS REGARDING THE DISCLOSURE AND MANAGEMENT OF CONFLICTS OF INTEREST. THESE POLICIES AND STANDARDS COVER ALL ASSOCIATION MEMBERS AND EMPLOYEES, DIRECTORS, OFFICERS, COMMITTEE MEMBERS, AND ANY PERSON IN A RELATIONSHIP WITH THESE INDIVIDUALS INVOLVING THE SHARING OF INCOME OR ASSETS (E.G. SPOUSE, DEPENDENT CHILDREN). COVERED INDIVIDUALS ARE ASKED TO DISCLOSE FINANCIAL INTERESTS IN OR OTHER RELATIONSHIPS WITH ENTITIES THAT HAVE RELEVANT COMMERCIAL INTERESTS, INCLUDING EMPLOYMENT OR LEADERSHIP POSITIONS, CONSULTANT OR ADVISORY ROLES, STOCK OWNERSHIP, HONORARIA, RESEARCH FUNDING, AND SERVICE AS AN EXPERT WITNESS. OFFICERS, DIRECTORS AND KEY EMPLOYEES ARE ALSO REQUIRED TO DISCLOSE SERVICE AS AN OFFICER, DIRECTOR, OR TRUSTEE OF ANY OTHER PROFESSIONAL OR ADVOCACY ORGANIZATION RELATING TO SCIENCE OR HEALTH CARE. COMPLETION OF A DISCLOSURE FORM IS REQUIRED AT THE INITIATION OF SERVICE AND UPDATED ANNUALLY THEREAFTER OR WHEN ANY MATERIAL CHANGES OCCUR. THE ASSOCIATION'S CONFLICT OF INTEREST POLICIES ARE INTENDED TO HELP GUIDE THE MANAGEMENT OF ACTUAL, POTENTIAL, AND PERCEIVED CONFLICTS OF INTEREST THROUGH DISCLOSURE OF FINANCIAL INTERESTS OR OTHER RELATIONSHIPS. WHERE THE NATURE AND EXTENT OF A FINANCIAL RELATIONSHIP SUGGEST DISCLOSURE IS NOT ADEQUATE TO MANAGE A REAL OR POTENTIAL CONFLICT, COVERED INDIVIDUALS ARE REQUIRED TO RECUSE THEMSELVES FROM DECISION MAKING. RECUSAL MAY BE SELF-SELECTED, OR MAY BE REQUESTED BY THE COMMITTEE CHAIR, OFFICER, OR EXECUTIVE-LEVEL STAFF MEMBERS. IN ADDITION, IF THE ASSOCIATION WERE TO CONTEMPLATE ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF ANY INTERESTED PERSON (I.E. A BOARD MEMBER, DIRECTOR, PRINCIPAL OFFICER, OR KEY EMPLOYEE WHO HAS A DIRECT OR INDIRECT FINANCIAL INTEREST IN THE TRANSACTION), IT MUST FOLLOW A SPECIFIC PROCEDURE TO MANAGE THE CONFLICT, INCLUDING CONSIDERING ALTERATIVE TRANSACTIONS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15B THE COMPENSATION OF THE ASSOCIATION'S VICE PRESIDENT OF MEMBER SERVICES WAS REVIEWED AND APPROVED BY INDEPENDENT PERSONS ON THE BASIS OF COMPARABILITY DATA, AND THE DELIBERATION AND DECISION WAS CONTEMPORANEOUSLY SUBSTANTIATED. THE ASSOCIATION'S COMPENSATION CONSULTANT, BASED ON THE ROLE'S RESPONSIBILITIES AND COMPARABILITY DATA, PROVIDED REASONABLENESS ASSURANCE FOR SUCH COMPENSATION. THIS REVIEW WAS LAST CONDUCTED IN 2022. FORM 990, PART VI, SECTION C, LINE 19 THE ASSOCIATION'S ARTICLES OF INCORPORATION ARE AVAILABLE ON THE VIRGINIA STATE CORPORATION COMMISSION WEBSITE. THE ASSOCIATION MAKES ITS BYLAWS AVAILABLE UPON REQUEST. THE ASSOCIATION'S CONFLICT OF INTEREST POLICY IS AVAILABLE ON THE ASCO WEBSITE. THE ASSOCIATION'S FINANCIAL STATEMENTS ARE NOT MADE AVAILABLE TO THE PUBLIC. FORM 990, PART VI, SECTION B, LINE 15A THE CHIEF EXECUTIVE OFFICER OF THE ASSOCIATION IS AN EMPLOYEE OF THE ASSOCIATION'S AFFILIATE, THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY (THE SOCIETY). INFORMATION REGARDING HIS COMPENSATION AND THE PROCESS FOR DETERMINING HIS COMPENSATION, INCLUDING REVIEW AND APPROVAL BY INDEPENDENT PERSONS, COMPARABILITY DATA, AND CONTEMPORANEOUS SUBSTANTIATION OF THE DELIBERATION AND DECISION, ARE DESCRIBED IN THE IRS FORM 990 OF THE SOCIETY. THE ASSOCIATION REIMBURSES THE SOCIETY FOR TIME SPENT ON ASSOCIATION MATTERS IN ACCORDANCE WITH A SHARED SERVICES AGREEMENT BETWEEN THE ENTITIES. FORM 990, PART IX, LINE 11G OTHER PROFESSIONAL SERVICES 2,080,831. QOPI CERTIFICATION PROGRAM LLC 2318 MILL RD SUITE 800 ALEXANDRIA VA 22314 271629211 ACCREDITATION VA 927058 483200 ASCO ASSOCIATION AMERICAN SOCIETY OF CLINICAL ONCOLOGY INC 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 136180380 RESEARCH/EDUCATION NY 501(C)(3) LINE 10 N/A 0 CONQUER CANCER FOUNDAITON OF ASCO 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 311667995 GRANTS VA 501(C)(3) LINE 7 ASCO 0 ASCO ASSOCIATION POLITICAL ACTION COMM 2318 MILL RD SUITE 800 ALEXANDRA VA 22314 844213157 ADVOCACY VA 527 ASCO ASSOC 1 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1 1 0 0